{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:20:48Z","timestamp":1795022448084,"version":"4.10.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:p>Erythritol, a widely used nonnutritive sweetener, has been linked to increased cardiovascular risk in observational studies. However, whether erythritol causally contributes to arterial and venous thrombotic diseases remains unclear. We performed a 2-sample Mendelian randomization (MR) study using 60 independent single nucleotide polymorphisms strongly associated with erythritol from a genome-wide association study of 8167 European individuals. Summary statistics for coronary heart disease, ischemic stroke, venous thromboembolism (VTE), pulmonary embolism (PE), and deep vein thrombosis (DVT) were obtained from the FinnGen consortium. The inverse-variance weighted method was the primary analysis, supplemented by MR-Egger, weighted median, and mode-based sensitivity analyses. Pleiotropy and heterogeneity were assessed. Genetically predicted higher erythritol levels were significantly associated with increased risks of coronary heart disease (odds ratio [OR]\u2005=\u20051.077, 95% confidence interval [CI]: 1.060\u20131.090) and ischemic stroke (OR\u2005=\u20051.157, 95% CI: 1.135\u20131.179), with consistent findings across sensitivity analyses and no evidence of pleiotropy. A suggestive association was observed for DVT (OR\u2005=\u20051.117, 95% CI: 1.077\u20131.158); however, causal effect directions for VTE and PE were inconsistent across MR methods. Additionally, MR-Egger intercept tests indicated potential horizontal pleiotropy for DVT, VTE, and PE. Our study suggests a potential role of erythritol in increasing the risk of coronary heart disease, ischemic stroke, and venous thromboembolism, which warrants further investigation.<\/jats:p>","DOI":"10.1097\/md.0000000000045187","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:02:45Z","timestamp":1761332565000},"page":"e45187","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Role of erythritol in coronary heart disease, ischemic stroke, and venous thromboembolism: A Mendelian randomization analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Yao","family":"Sun","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingxin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shuangliao Hospital of Traditional Chinese Medicine, Shuangliao, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiao","family":"Wu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Peng","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jin","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1161\/ATVBAHA.124.321019","article-title":"Ingestion of the non-nutritive sweetener erythritol, but not glucose, enhances platelet reactivity and thrombosis potential in healthy volunteers-brief report.","volume":"44","author":"Witkowski","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/clinchem\/hvad069","article-title":"Is the nonnutritive sweetener erythritol or its circulating metabolite a risk factor for cardiovascular events?","volume":"69","author":"Heianza","year":"2023","journal-title":"Clin Chem"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"101605","DOI":"10.1016\/j.jacadv.2025.101605","article-title":"Erythritol, erythronate, and cardiovascular outcomes in older adults in the ARIC study.","volume":"4","author":"Abushamat","year":"2025","journal-title":"JACC Adv"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.3390\/nu15184011","article-title":"Elevated erythritol: a marker of metabolic dysregulation or contributor to the pathogenesis of cardiometabolic disease?","volume":"15","author":"Mazi","year":"2023","journal-title":"Nutrients"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41392-023-01504-6","article-title":"The sugar-free paradox: cardiometabolic consequences of erythritol.","volume":"8","author":"Pafili","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1093\/eurheartj\/ehae729","article-title":"Erythritol and xylitol and cardiovascular disease risk: a growing concern.","volume":"46","author":"Witkowski","year":"2025","journal-title":"Eur Heart J"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jand.2016.11.004","article-title":"Consumption of low-calorie sweeteners among children and adults in the United States.","volume":"117","author":"Sylvetsky","year":"2017","journal-title":"J Acad Nutr Diet"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41591-023-02223-9","article-title":"The artificial sweetener erythritol and cardiovascular event risk.","volume":"29","author":"Witkowski","year":"2023","journal-title":"Nat Med"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/eurjpc\/zwae288","article-title":"Plasma levels of polyols erythritol, mannitol, and sorbitol and incident coronary heart disease among women.","volume":"32","author":"Heianza","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/ATVBAHA.118.312236","article-title":"Metabolomic pattern predicts incident coronary heart disease.","volume":"39","author":"Wang","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"e071204","DOI":"10.1136\/bmj-2022-071204","article-title":"Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Sante cohort.","volume":"378","author":"Debras","year":"2022","journal-title":"BMJ"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2337\/db23-0330","article-title":"Erythritol as a potential causal contributor to cardiometabolic disease: a Mendelian randomization study.","volume":"73","author":"Khafagy","year":"2024","journal-title":"Diabetes"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption.","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation.","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk.","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/metabo12020123","article-title":"Why do high-risk patients develop or not develop coronary artery disease? Metabolic insights from the CAPIRE study.","volume":"12","author":"Deidda","year":"2022","journal-title":"Metabolites"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3390\/nu16183099","article-title":"Serum erythritol and risk of overall and cause-specific mortality in a cohort of men.","volume":"16","author":"Lim","year":"2024","journal-title":"Nutrients"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1152\/japplphysiol.00276.2025","article-title":"The non-nutritive sweetener erythritol adversely affects brain microvascular endothelial cell function.","volume":"138","author":"Berry","year":"2025","journal-title":"J Appl Physiol (1985)"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s40064-015-1063-y","article-title":"Altered cytotoxicity of ROS-inducing compounds by sodium pyruvate in cell culture medium depends on the location of ROS generation.","volume":"4","author":"Kelts","year":"2015","journal-title":"Springerplus"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/5584_2016_121","article-title":"Venous and arterial thrombosis: is there a link?","volume":"906","author":"Prandoni","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"295","DOI":"10.23736\/S0392-9590.17.03820-2","article-title":"Interrelationship between venous and arterial thrombosis.","volume":"36","author":"Poredos","year":"2017","journal-title":"Int Angiol"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12195-021-00713-9","article-title":"Characterization of atherosclerotic plaque coating for thrombosis microfluidics assays.","volume":"15","author":"Karel","year":"2022","journal-title":"Cell Mol Bioeng"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"110349","DOI":"10.1016\/j.jbiomech.2021.110349","article-title":"Mechanobiology of shear-induced platelet aggregation leading to occlusive arterial thrombosis: a multiscale in silico analysis.","volume":"120","author":"Liu","year":"2021","journal-title":"J Biomech"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pin.13305","article-title":"Underlying mechanisms of thrombus formation\/growth in atherothrombosis and deep vein thrombosis.","volume":"73","author":"Yamashita","year":"2023","journal-title":"Pathol Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:02:09Z","timestamp":1795021329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":30,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045187","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2025-07-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}